Loading provider…
Loading provider…
Ophthalmology Physician in San Francisco, CA
NPI: 1326081977Primary Practice Location
UCSF MEDICAL CENTER
1975 4th St, San Francisco, CA
Primary Employer
UCSF Proctor Medical Group
ucsf.edu
HQ Phone
Get M.D. Gerami's Phone Numberphone_androidMobile
Get M.D. Gerami's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardMD State Medical License
CA State Medical License
CA State Medical License
2017 - 2026
MD State Medical License
2004 - 2021
MI State Medical License
1999 - 2000

American Board of Ophthalmology
Ophthalmology
Johns Hopkins University
Residency • Ophthalmology
2000 - 2003
Trinity Health Ann Arbor Hospital
Internship • Internal Medicine
1999 - 2000
University Of Michigan Medical School
medschool.umich.edu
Medical School
Until 1999
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99214Established patient office or other outpatient visit, 30-39 minutes | 95 | 142 |
| 2 | 99213Established patient office or other outpatient visit, typically 15 minutes | 82 | 109 |
| 3 | 92285Photography of content of eyes | 40 | 53 |
| 4 | 92014Eye and medical examination for diagnosis and treatment, established patient, 1 or more visits | 24 | 24 |
| 5 | 92133Diagnostic imaging of optic nerve of eye | 21 | 21 |
Multimodal imaging in paraproteinemic keratopathy.
Authors: Neel Pasricha, Michele Lee
Journal: Indian J Ophthalmol
Ligneous Conjunctivitis Treated with Intravenous Human Plasminogen.
Authors: Saban, Ori, Seitzman, Gerami D
Journal: Ophthalmology
Publication Date: 2025-02-17
Delayed Acute Granulomatous Anterior Uveitis after Inadvertent Intraocular Injection of Tattoo Ink from a Scleral Tattoo Procedure.
Authors: Neel Pasricha, Zeeshan Haq, Jay Stewart
Publication Date: 2020-08-20
Lead Sponsor: Jeremy Keenan, MD, MPH
Collaborators: National Eye Institute (NEI), University of Pennsylvania, University of California, Los Angeles, University of Miami, University of Iowa, Columbia University, Oregon Health and Science University, University of Pittsburgh, University of Florida, Johns Hopkins University, University of Illinois at Chicago, Aravind Eye Care System, Moorfields Eye Hospital NHS Foundation Trust, Federal University of São Paulo
Intervention / Treatment: DRUG: Topical corticosteroid, OTHER: Topical placebo, DRUG: Polyhexamethylene biguanide (PHMB)
Lead Sponsor: University of California, San Francisco
Intervention / Treatment: DRUG: Placebo, DRUG: Doxycycline 40 MG ( 20mg twice daily), DRUG: Doxycycline 200 MG ( 100 mg twice daily)
Lead Sponsor: Thomas M. Lietman
Collaborators: National Eye Institute (NEI), Stanford University, University of Miami, Aravind Eye Care System
Intervention / Treatment: OTHER: Topical Placebo, DRUG: Riboflavin Ophthalmic, DRUG: Moxifloxacin Ophthalmic, DRUG: Difluprednate Ophthalmic